Parth Mehrotra - Nov 2, 2021 Form 4 Insider Report for Privia Health Group, Inc. (PRVA)

Role: President and COO
Signature: /s/ Thomas Bartrum, as attorney-in-fact
Stock symbol: PRVA
Transactions as of: Nov 2, 2021
Transactions value $: -$117,560
Form type: 4
Date filed: 11/4/2021, 07:56 PM
Next filing: Nov 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PRVA	Common Stock, $0.01 par value per share	Options Exercise	$10K	+5K	+3.44%	$2.00^*	150K	Nov 2, 2021	Direct	F1
transaction	PRVA	Common Stock, $0.01 par value per share	Sale	-$128K	-5K	-3.33%	$25.51	145K	Nov 2, 2021	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PRVA	Stock Option (Right to Purchase)	Options Exercise	$0	-5K	-0.26%	$0.00	1.89M	Nov 2, 2021	Common Stock	5K	$2.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 47,825 shares of common stock, par value $0.01 per share (the "Common Stock"), of Privia Health Group, Inc. received by the reporting person in a pro rata distribution of Common Stock by Brighton Health Group Holdings, Inc. to its members on May 11, 2021.
F2	The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2021.
F3	The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.24 to $25.74 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.